Crossmark

Safety and efficacy of T-cell-redirecting bispecific antibodies for patients with multiple myeloma: a systematic review and meta-analysis

Published Online: 2023-09-05

Authors

Noori, Maryam

Yazdanpanah, Niloufar

Rezaei, Nima
License Information

Text and Data Mining valid from 2023-09-05

Version of Record valid from 2023-09-05
More Information

Article History

Received: 24 June 2023

Accepted: 28 August 2023

First Online: 5 September 2023

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current